Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,437 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07296601Enrolling by invitation
Expert consensus on using skin boosters
This study gathers expert dermatologists and aesthetic doctors to create a consensus guideline on how to best use skin boosters (injectable treatments that improve skin hydration and texture). If you are an experienced provider, your opinion can help shape practice recommendations.
CairoAges Any age - NCT07296549Enrolling by invitation
Expert input on melasma treatment choices
This study gathers expert dermatologists to create guidelines for managing melasma, a skin condition that causes dark patches. If you are an experienced dermatologist, your opinion could help shape future care.
CairoAges 25 years+ - NCT07293663Recruiting
Studying ways to teach NG tube insertion to nursing students
This trial compares three ways of teaching nursing students how to insert a nasogastric (NG) tube, a thin tube placed through the nose into the stomach. The goal is to see which teaching method works best for students who have never done this before.
TurkuAges 18 years+ - NCT07292376Enrolling by invitation
Preventing blood clots in cancer outpatients
This trial is testing a program to help prevent blood clots in people with cancer who are starting a new type of cancer treatment, like chemotherapy or targeted therapy. The goal is to see if better prevention strategies can keep you safe during treatment.
Burlington, VermontAges 18 years+ - NCT07295236Recruiting
Vacuum therapy for a leak after stomach surgery
This trial tests whether a treatment called endoscopic vacuum therapy can help heal a small leak that can happen after stomach removal surgery. If you are stable and the leak is small, this treatment may help you avoid more surgery.
KyivAges 18–90 - NCT07291011Recruiting
Mindfulness for underserved cancer patients in Minnesota
This study tests an online mindfulness program (stress-reducing techniques) to help people with cancer who live in rural areas feel better emotionally. It is designed for those who are feeling significant distress.
Rochester, MinnesotaAges Any age - NCT07289737Recruiting
Comparing two spine surgeries for a slipped backbone
This study compares two types of spine surgery for a common condition where a lower back bone slips forward. It aims to see which surgery works better to relieve pain and improve function.
Yiwu, ZhejiangAges 50–90 - NCT07288788Recruiting
Kidney function in children with epilepsy
This study looks at how well the kidneys work in children who have epilepsy. It may help doctors understand how epilepsy or its treatment affects kidney health.
SohagAges 1 month–15 years - NCT07292779Recruiting
Testing a new filler for smile lines
This study tests a new injectable treatment, DMFI150, for smile lines (nasolabial folds). It aims to see if it can safely reduce their appearance. You may qualify if your smile lines are moderate to severe and you are not taking certain medications.
MarbellaAges 18–70 - NCT07288580RecruitingPhase 1/Phase 2
Gene therapy for children with inherited deafness
This trial tests an injection called EHT102 for children who have severe or profound hearing loss due to mutations in the Otoferlin gene. The goal is to see if the treatment can restore or improve hearing.
Shanghai, Shanghai MunicipalityAges 1–17 - NCT07293923Recruiting
Magenta Elevate™ study for cardiogenic shock
This trial tests a new heart pump called the Magenta Elevate™ to help people whose heart suddenly stops pumping enough blood (cardiogenic shock). It aims to improve blood flow and reduce strain on the heart.
TbilisiAges 40–89 - NCT07290790Recruiting
Trimline Aligner Accuracy Study
This trial tests SureSmile clear aligners to see how accurately they fix common bite problems like crowding, spacing, and overbite. You may be able to join if you need mild to moderate orthodontic treatment.
Fresno, CaliforniaAges 18 years+ - NCT07289477RecruitingPhase 1
Study of NouvNeu001 for Multiple System Atrophy
This study tests a new injection called NouvNeu001 for people with Multiple System Atrophy (MSA). The goal is to see if it can help control symptoms that standard treatments aren't managing well.
Beijing, Beijing MunicipalityAges 30–70 - NCT07292441RecruitingPhase 3
Long-term weight loss study for trial participants
This study is for people who finished a previous weight loss trial and want to continue treatment with an injectable medication GZR18. It tests how well the medicine works over a longer period.
Beijing, Beijing MunicipalityAges 18–75 - NCT07288515Recruiting
Acalabrutinib for CLL in routine care
This study follows people with CLL who are starting acalabrutinib (a targeted pill) for the first time, either as their first treatment or after previous therapies. The goal is to see how well it works in everyday medical practice.
GrodnoAges 18 years+ - NCT07289763RecruitingPhase 2
Study of SHR-2173 for primary membranous nephropathy
This trial tests an investigational drug called SHR-2173 for people with primary membranous nephropathy, a kidney disease that causes protein leakage. The study aims to see if the drug is safe and effective, and it involves periodic injections and monitoring.
Nanjing, JiangsuAges 18–75 - NCT05816655RecruitingPhase 2
Test two hormone treatment combinations for metastatic breast cancer
This Phase 2 study compares two combinations of hormone-blocking drugs plus an anti-cancer targeted pill to see which works better for hormone-receptor positive, HER2-negative metastatic breast cancer. It may help by finding a more effective treatment plan when the cancer has spread.
SeoulAges 19–80 - NCT06758037RecruitingPhase 2
HiR Plus X therapy for elderly DLBCL patients who can't have chemo
This study tests a new treatment called HiR+X for older adults with a type of lymphoma (DLBCL) who cannot tolerate standard chemotherapy. It aims to offer a gentler but effective option.
Ningbo, ZhejiangAges 70–100 - NCT06881069Recruiting
Text-based tobacco cessation support for low-income Utahns
This study tests a text-message program to help people who use tobacco quit. It's designed for adults living in low-income areas in Utah who visit certain clinics.
Salt Lake City, UtahAges 18 years+ - NCT06881771Recruiting
Tracking Fuchs' dystrophy progression and genetics in the UK
This study follows people with Fuchs' endothelial corneal dystrophy over time to see how the condition changes and how it relates to their genes. It aims to help doctors better predict and manage the disease.
LondonAges 18 years+ - NCT05728957Recruiting
Biopsy and special scan for small kidney tumors
This trial studies using a kidney tumor biopsy and a special nuclear scan (SPECT/CT using sestamibi) to help evaluate kidney tumors before surgery. It may help doctors better characterize tumors that appear suspicious on imaging.
Maywood, IllinoisAges 18 years+ - NCT06693934Recruiting
Prevention program for young adults at risk of diabetes
This trial offers a prevention program for young adults aged 18 to 44 who have at least one risk factor for diabetes but do not already have diabetes. The program aims to help prevent or delay the onset of diabetes.
Hong KongAges 18–44 - NCT07284420RecruitingPhase 2
Testing empasiprubart with efgartigimod for myasthenia gravis
This study adds a new drug called empasiprubart to the existing treatment efgartigimod for people with generalized myasthenia gravis (gMG) who have antibodies against acetylcholine receptors (AChR-Ab) and have only partially responded to efgartigimod. The goal is to see if the combination improves daily living more than efgartigimod alone.
Carlsbad, CaliforniaAges 18 years+ - NCT07286890Recruiting
Beating Heart Bypass Surgery Study with Getinge Devices
This study follows patients who have a type of heart bypass surgery called 'beating heart' CABG, where a special Getinge device is used to keep the heart pumping during the operation. It helps doctors learn more about how well these devices work in real-world use.
Stockton, CaliforniaAges 22 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,437 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.